%PDF-1.6
%
1 0 obj
<< /Lang (en-US) /Metadata 3 0 R /OutputIntents [ << /DestOutputProfile 4 0 R /Info (U.S. Web Coated \(SWOP\) v2) /OutputConditionIdentifier (CGATS TR 001) /RegistryName (http://www.color.org) /S /GTS_PDFX /Type /OutputIntent >> ] /Pages 5 0 R /Type /Catalog /ViewerPreferences << /Direction /L2R >> >>
endobj
2 0 obj
<< /CreationDate (D:20220622171622-04'00') /Creator (Adobe InDesign 17.2 \(Macintosh\)) /GTS_PDFXVersion (PDF/X-4) /ModDate (D:20220622171624-04'00') /Producer (Adobe PDF Library 16.0.7) /Title (M43033 Clinical Brief Revos Fatty Tissue M&A.indd) /Trapped /False >>
endobj
3 0 obj
<< /Subtype /XML /Type /Metadata /Length 2966 >>
stream
2022-06-22T17:16:22-04:00
2022-06-22T17:16:24-04:00
2022-06-22T17:16:24-04:00
Adobe InDesign 17.2 (Macintosh)
uuid:14984adb-0b27-494f-8e5d-63a206ea128f
xmp.did:3c08b937-dd3e-4d3c-881e-4088c84de1bd
xmp.id:257302aa-cef8-4a48-81ce-de9577eedb76
proof:pdf
1
xmp.iid:bd38832b-12a1-40e7-8d7d-e9422a7e840e
xmp.did:bd38832b-12a1-40e7-8d7d-e9422a7e840e
xmp.did:3c08b937-dd3e-4d3c-881e-4088c84de1bd
default
converted
from application/x-indesign to application/pdf
Adobe InDesign 17.2 (Macintosh)
/
2022-06-22T17:16:22-04:00
application/pdf
M43033 Clinical Brief Revos Fatty Tissue M&A.indd
Adobe PDF Library 16.0.7
False
PDF/X-4
PDF/X-4
endstream
endobj
4 0 obj
<< /Filter /FlateDecode /N 4 /Length 389757 >>
stream
HuTKtKKJI,t(4K%ҹH4J#Ғ(H
wqyy~3̙g<3 Y9El
@ ]!O-@ \+BVKK
:OX~WCaiHKL 0qY `5 ck
X] x=8 X Ŀ>.f#aPn D^{y8 dpH st:Yc xc
IV?S!:_9[YbQP~+rA
ShHht^
'0߅kYXY9Yqqpl'WzEE$%D>,^|t*K)%/`\ҫ:&D[7dplDa5|mb4,yy{e5
3⚅,t+whlA
mk
xYUH&%Ȥ
qO'Mz3KT@v[NUnn^\o]abTrtlmE]e~U+jאZ:zaqi5};CS[\_ۆwCaQ1;>L$Lz}4:%8M7l̎Χ/}XT^]X>\Ym[n!ycskkƶʷ;v{pIs0Xݯ3s&$WWW*)!$$%!e$cHNOAKIMEqƕ;KLw@YX;ؚ8^+DspfKOTCPpJ%D=++O%$*8IZ\Z^UK_wL"dx]} >9=;s_G8/̹N!Gz[<=2|B}PQzlH0Wc(Een|Pds::5&89yFT"od䳔i/ZK^&gd:fgQl
kJХeJ*+篍kj5U[ZUh0|em6]B@`PpH?QM1Msψ*iϛ.Z[JYZ)X-]RѺپw?@?5 ǖ'vNg
W3gLC#u!MMMEvAms˔FVNA̝GLwA̬,llؿsݛnͽ+!B²" 'R&k?3?4+:6oT\ұڿ6VʝoF?LT;:>::>:;eqvx^sawݥʕ'_ EFO\DKLtAnFF)F|ԭ6\`@z?m+F;LwiA hy͖)Mgw~_
@ZH_XA,"F)%/*9aZ:Q,\B^_AU2
*'[jo5[uR1uh`fm$1xJgBdrltlyyEe$feg-g#`dGbwj0TOC9; ܨݿxz6zx8IP=A!.aAxۑ ϊ}bG-ޒēx`G/Ԝq_O?0"۬խЮ˯ǰı²µŶȷӹۺ 0@RfzƏǦȾ*GcЀџҿ'LsٛFsM6+1MZ:{ T?~ò~i~L}~cbA~Dad~ty~W~O>~\/~|~`C x}%H}1X}%z}K}
{N}<_~7A~-ψ||Dz|+E|[s|z}^}wO@}-~ċ {Gu{Dz{]Ĭ{f{Zx|[]|ϕM?}R<}Ǝz]YzHħz|z={LNw{\|=>|v|ېI8z/r
z;bz'sMzd6zɬqv{D[{0>|;|yyaIy?yazYvzݮ[{^=c{ФI{R*y߄yfUy`VyyuKzZi{<{z%zȎ~+~ }͇}W0}3}HtЄ}Zk}=~zɇ }!~Єd*s}Y<9wpSwuuVrUW؈|;,뇔{RsѲ;:8q)PCV:4.8Ȅ2?UpVu9ScbփR.ՁNn U388A/ͬδz6߆өn1T\e7݀tXT)$̯̕6;eCʷˆ imw3SƀV7M
\lGNػځNāa5tNzlߴS<H6*